Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats.
Plasma protein binding and pharmacokinetic parameters of CHIP (cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV) and CBDCA (cis-diammine-1,1-cyclobutane dicarboxylate platinum II) were investigated in male Wistar rats. The plasma clearance of total and non-protein-bound platinum was determined and compared with that of 99mTc-DTPA. For binding experiments, a novel, simple, and quick method based on adsorption of non-protein-bound platinum species to charcoal was used. The clearance of total platinum after CHIP and CBDCA administration was markedly lower than the glomerular filtration rate (determined as the clearance of 99mTc-DTPA). The renal clearance of non-protein-bound platinum corresponded to 168% and 50% of the glomerular filtration rate for CHIP and CBDCA, respectively. These studies suggested that CHIP was excreted by the rat kidney.
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D016190:Carboplatin; D005919:Glomerular Filtration Rate; D007700:Kinetics; D008657:Metabolic Clearance Rate; D009944:Organoplatinum Compounds / Q000378:metabolism*; D004369:Pentetic Acid / Q000378:metabolism; D011485:Protein Binding; D051381:Rats
D001798:Blood Proteins; D009944:Organoplatinum Compounds; C023359:iproplatin; D004369:Pentetic Acid; D016190:Carboplatin